Concepedia

Bizhi Shi

BS

Statistics

Publications

46

Citations

3.3K

H-Index

30

Active since

2005

Affiliations

State Key Laboratory of Oncogene and Related Genes(Current)

Shanghai Cancer Institute

Renji Hospital

Shanghai Jiao Tong University

Shanghai Medical College of Fudan University

Bizhi Shi is an author at State Key Laboratory of Oncogene and Related Genes specializing in oncology, cancer immunotherapy, and cancer immunology.

Publications per year

2005–2024

46

Publications

46

Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

Huiping Gao, Kesang Li, Hong Tu et al. · Clinical Cancer Research · 2014 · 308 citations

, , +12

Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer

Hua Jiang, Zhimin Shi, Peng Wang et al. · JNCI Journal of the National Cancer Institute · 2018 · 248 citations

, , +17

Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma

Xingliang Guo, Hua Jiang, Bizhi Shi et al. · Frontiers in Pharmacology · 2018 · 205 citations · Full text

, , +17

Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma

Min Yu, Hong Luo, Mingliang Fan et al. · Molecular Therapy · 2017 · 185 citations · Full text

, , +16

Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion

Hong Luo, Su Jingwen, Ruixin Sun et al. · Clinical Cancer Research · 2020 · 179 citations · Full text

, , +17

1–5 of 46